Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,332 | 5,876 | 3,921 | 8,904 | 13,563 |
| Marketable Securities | 31 | 31 | 31 | 33 | 33 |
| Receivables | N/A | N/A | N/A | N/A | 99 |
| TOTAL | $4,409 | $6,904 | $5,359 | $10,162 | $14,210 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 1 | 3 | 5 |
| Intangibles | 20 | 21 | 22 | 25 | 26 |
| TOTAL | $20 | $21 | $23 | $27 | $31 |
| Total Assets | $4,428 | $6,925 | $5,382 | $10,189 | $14,241 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,987 | 2,975 | 1,795 | 888 | 636 |
| Accrued Expenses | 1,719 | 3,438 | 1,304 | 986 | 735 |
| TOTAL | $8,706 | $6,413 | $3,099 | $1,874 | $1,371 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,902 | 1,859 | 1,553 | 1,605 | 9,185 |
| TOTAL | $1,902 | $1,859 | $1,553 | $1,605 | $9,185 |
| Total Liabilities | $10,607 | $8,272 | $4,652 | $3,479 | $10,555 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 343 | 343 | 343 | 288 | N/A |
| Common Shares | N/A | N/A | N/A | N/A | 56,887 |
| Retained earnings | -85,213 | -80,254 | -72,988 | -67,031 | -67,994 |
| Other shareholders' equity | -200 | -195 | -270 | -139 | 7,121 |
| TOTAL | $-6,179 | $-1,348 | $730 | $6,710 | $3,686 |
| Total Liabilities And Equity | $4,428 | $6,925 | $5,382 | $10,189 | $14,241 |